Westside Investment Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14 | Hold |
12
| – | – | ﹤0.01% | 1277 |
|
|
2025
Q1 | $16 | Hold |
12
| – | – | ﹤0.01% | 973 |
|
|
2024
Q4 | $28 | Sell |
12
-1
| -8% | -$2 | ﹤0.01% | 978 |
|
|
2024
Q3 | $46 | Hold |
13
| – | – | ﹤0.01% | 983 |
|
|
2024
Q2 | $68 | Hold |
13
| – | – | ﹤0.01% | 975 |
|
|
2024
Q1 | $112 | Hold |
13
| – | – | ﹤0.01% | 886 |
|
|
2023
Q4 | $54 | Hold |
13
| – | – | ﹤0.01% | 860 |
|
|
2023
Q3 | $40 | Hold |
13
| – | – | ﹤0.01% | 835 |
|
|
2023
Q2 | $412 | Hold |
13
| – | – | ﹤0.01% | 817 |
|
|
2023
Q1 | $660 | Hold |
13
| – | – | ﹤0.01% | 807 |
|
|
2022
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 801 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 802 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 797 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 775 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 774 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 746 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 736 |
|
|
2021
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 716 |
|
|
2020
Q4 | $1 | Hold |
13
| – | – | ﹤0.01% | 621 |
|
|
2020
Q3 | $3 | Hold |
13
| – | – | ﹤0.01% | 585 |
|
|
2020
Q2 | $2 | Buy |
+13
| New | +$2 | ﹤0.01% | 594 |
|